Skip to main content

Year: 2021

LiveWire Ergogenics Expands Estrella Ranch Cultivation Area to over 130,000 Square Feet to Meet Demand by Popular California Brands

Anaheim, CA, Dec. 22, 2021 (GLOBE NEWSWIRE) — LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring, managing, and licensing special purpose real estate properties conducive to producing high-quality, handcrafted, and organically grown cannabis products for medical and recreational adult-use in California; today announced that the expansion of the cultivation area on Estrella Ranch by two additional acres is in the advanced stage. The expansion will increase the canopy area to over 130,000sf of cultivation for Estrella River Farms (“ERF”), with a majority of the additional acreage already reserved for cooperation with several popular third party California cannabis brands under private label. Bill Hodson, CEO of Livewire Ergogenics, states, “Our affiliate company, Estrella River Farms (ERF), has...

Continue reading

Triller to the “ILLR” – Triller Hold Co LLC expected to become publicly traded on Nasdaq through a reverse merger with publicly-traded company SeaChange International, Inc. (NASDAQ: SEAC)

Upon closing, ticker symbol to be changed to “ILLR” and company name to be changed to TrillerVerz Corp.Transaction expected to ultimately value TrillerVerz at approximately $5 billion.Definitive documents and deal terms signed, including a support agreement from SeaChange’s largest shareholder. The Transaction is expected to close in Q1 2022.SeaChange to become a business unit inside of TrillerVerz focused on cable, streaming and advertising.LOS ANGELES and BOSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) — SeaChange International, Inc. (“SeaChange”) (NASD:SEAC) together with Triller Hold Co LLC (“TrillerVerz” or the “Company”) today announced that they have entered into a definitive agreement and plan of merger (the “Merger Agreement”) to combine with SeaChange, a publicly-traded company focused...

Continue reading

Live Ventures Announces Fiscal 2021 Financial Results

LAS VEGAS, Dec. 22, 2021 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company, today announced financial results for its year ended September 30, 2021.  Fiscal Year 2021 Key Highlights:Revenues of $273.0 million increased 42% over the prior year period; Gross profit of $99.5 million increased 32% over the prior year period; Operating income of $35.8 million increased 75% over the prior year period; Net income of $31.2 million increased 186% over the prior year period; Fiscal Year 2021 Basic and Fully Diluted EPS were $19.92 and $9.80, respectively, increased 211% and 217%, respectively, over the prior year period; Total assets of $211.7 million; Acquired an interest in Salomon Whitney Financial in June 2021; Repurchased 35,435 shares of common stock at an average price of $11.88 per share;...

Continue reading

Sachem Capital Corp. Announces Dividend of $0.12 Per Share

BRANFORD, Conn., Dec. 22, 2021 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) announced today that its board of directors authorized and declared a quarterly dividend of $0.12 per share to be paid to shareholders of record as of the close of trading on the NYSE American on December 31, 2021. The dividend will be payable on January 10, 2022. John Villano, CPA, Chief Executive Officer of Sachem Capital Corp., stated, “We are pleased to announce this latest dividend reflecting our strong financial performance for 2021.   We remain highly encouraged by the outlook for 2022 and believe we are well positioned as a leading non-bank real estate lender to capitalize on new lending opportunities.” About Sachem Capital Corp. Sachem Capital Corp. specializes in originating, underwriting, funding, servicing, and managing a portfolio...

Continue reading

Coiled Tubing Market to rise at CAGR of 5.37% through 2030 – Report by Market Research Future (MRFR)

New York, Dec. 22, 2021 (GLOBE NEWSWIRE) — Coiled Tubing Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Coiled Tubing Market   Research Report: Information, By Service Type (Well Intervention, Drilling and others), By Application (Onshore and Offshore) – Forecast till 2030”. Market Research Future’s Review on Coiled Tubing Market The global coiled tubing market will grow at a 5.37% CAGR by 2030, states the latest Market Research Future report. Eminent industry players profiled in the global coiled tubing market report includeSchlumberger (US) Halliburton (US) Weatherford (US) Baker Hughes a GE Company LLC (US) Nabors Industries Ltd (UK) C&J Energy Services Inc (US) Trican (Canada) Calfrac Well Services Ltd (Canada) RPC Inc (US) Step Energy Services Ltd (US) Key Energy...

Continue reading

Medicenna Announces Preliminary Clinical Data Showing Preferential Stimulation of Anti-Cancer Immune Cells with MDNA11 Treatment in the Phase 1/2 ABILITY Study

— Peak CD8+ T cell (anti-tumor) / Treg (pro-tumor) ratio increased ~2-3 fold over baseline with MDNA11 treatment in the trial’s first two dose escalation cohorts — MDNA11-induced increases in CD8+ T and NK cells compare favorably to competing IL-2 variants in the clinic — No dose limiting toxicity, or any evidence of cytokine release syndrome, nor any evidence of vascular leak syndrome has been observed TORONTO and HOUSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced preliminary data from the Phase 1/2 ABILITY (A Beta-only IL-2 ImmunoTherapY) study of MDNA11, the Company’s selective, long-acting and novel IL-2 super-agonist. Key findings from the ABILITY study’s first two dose escalation...

Continue reading

Outlook Therapeutics Reports Financial Results for Fiscal Year 2021 and Provides Corporate Update

Positive clinical data reported for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) in 2021 from multiple clinical trials, including statistically significant top-line efficacy and safety data from pivotal Phase 3 NORSE TWO trial for wet age-related macular degeneration (wet AMD)Recent financing activities expected to provide funding through the anticipated approval of the ONS-5010 biologics license application (BLA) expected in the first calendar quarter of 2023Pre-launch commercial planning underway in anticipation of ONS-5010 approvalISELIN, N.J., Dec. 22, 2021 (GLOBE NEWSWIRE) —  Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced recent corporate highlights and financial...

Continue reading

Inspire Medical Systems, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 22, 2021 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022. Inspire is scheduled to present at 9:45 a.m. Eastern Time. The presentation will be accessible via a live webcast at:https://jpmorgan.metameetings.net/events/healthcare22/sessions/40114-inspire-medical-systems-inc/webcast?gpu_only=true&kiosk=true A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com. About...

Continue reading

Operation and Maintenance Contract Renewed in Mississippi

All amounts in Canadian dollars unless otherwise stated. QUEBEC CITY, Dec. 22, 2021 (GLOBE NEWSWIRE) — (TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is proud to announce that it has recently renewed the operation, management and maintenance (“O&M”) contract with the City of Long Beach, Mississippi, for an additional period of four years. This contract, valued at $12.0 M, brings the Corporation’s O&M backlog to $86.8 M. This renewal includes annual consumer price index (CPI) increases, scope expansion and the addition of five new full-time resources. “We are proud of this long-lasting relationship and thankful that the City has entrusted us to operate, manage and maintain their infrastructure. With the renewal of this project, our O&M contract renewal rate is maintained at 99%! This would...

Continue reading

OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes

ROCHESTER, Mich., Dec. 22, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today issued an open letter from the CEO to shareholders detailing the completion of internal management changes. The full letter is published below: Dear OptimizeRx Shareholders, I am proud to say that OptimizeRx has evolved into a company strategically focused on the digital enablement of communication among the pharmaceutical industry, physicians and patients. With a compounded annual growth rate of 45% over the last three years and a present market capitalization of nearly $1 billion dollars, we believe that we are ideally positioned in a nascent industry to consistently win new business and mature our existing businesses to scale. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.